Benzylmorpholine Analogs as Selective Inhibitors of Lung Cytochrome P450 2A13 for the Chemoprevention of Lung Cancer in Tobacco Users
4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), one of the most prevalent and procarcinogenic compounds in tobacco, is bioactivated by respiratory cytochrome P450 (CYP) 2A13, forming DNA adducts and initiating lung cancer. CYP2A13 inhibition offers a novel strategy for chemoprevention of tobacco-associated lung cancer.
Twenty-four analogs of a 4-benzylmorpholine scaffold identified by high throughput screening were evaluated for binding and inhibition of both functional human CYP2A enzymes, CYP2A13 and the 94%-identical hepatic CYP2A6, whose inhibition is undesirable. Thus, selectivity is a major challenge in compound design.
A key feature resulting in CYP2A13-selective binding and inhibition was substitution at the benzyl ortho position, with three analogs being >25-fold selective for CYP2A13 over CYP2A6.
Two such analogs were negative for genetic and hERG toxicities and metabolically stable in human lung microsomes, but displayed rapid metabolism in human liver and in mouse and rat lung and liver microsomes, likely due to CYP2B-mediated degradation. A specialized knockout mouse mimicking the human lung demonstrates compound persistence in lung and provides an appropriate test model. Compound delivered by inhalation may be effective in the lung but rapidly cleared otherwise, limiting systemic exposure.
KEY WORDSchemopreventative cytochrome P450 2A13 cytochrome P450 2A6 lung cancer tobacco
Human ether-a-go-go-related gene
Equilibrium dissociation constant
NADPH-cytochrome P450 oxidoreductase
Structure activity relationship
ACKNOWLEDGMENTS AND DISCLOSURES
Thanks are due to Kelin Li, who provided synthetic training to LB. We are grateful for purity analysis by Patrick Porubsky and Ben Neuenswander at The University of Kansas Center for Chemical Methodologies and Library Design. Toxicity studies were undertaken at Cerep. Metabolic stability in microsomes was undertaken at Xenotech, LLC. Mike Wester facilitated metabolic screening with the major human xenobiotic metabolizing CYP enzymes. Transgenic microsomes were a gift from Xinxin Ding at the Wadsworth Center, New York State Department of Health and State University of New York at Albany. This work was supported by the Kansas Masonic Cancer Research Institute, the University of Kansas General Research Fund, NIH grant NIGMS GM076343, and the Institute for Advancing Medical Innovation.
- 7.World Health Organization. Cancer. http://www.who.int/mediacentre/factsheets/fs297/en/ (accessed 11/14/08).
- 8.American Cancer Society. Cancer Facts and Figures 2012, Atlanta, 2012.Google Scholar
- 9.Center for Disease Control. Smoking and Tobacco Use. http://www.cdc.gov/tobacco/data_statistics/fact_sheets/index.htm.
- 13.Wang H, Tan W, Hao B, Miao X, Zhou G, He F, et al. Substantial reduction in risk of lung adenocarcinoma associated with genetic polymorphism in CYP2A13, the most active cytochrome P450 for the metabolic activation of tobacco-specific carcinogen NNK. Cancer Res. 2003;63(22):8057–61.PubMedGoogle Scholar
- 17.Hecht SS, Trushin N, Rigotty J, Carmella SG, Borukhova A, Akerkar S, et al. Complete inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced rat lung tumorigenesis and favorable modification of biomarkers by phenethyl isothiocyanate. Cancer Epidemiol Biomarkers Prev. 1996;5(8):645–52.PubMedGoogle Scholar
- 21.Su T, Bao Z, Zhang Q-Y, Smith TJ, Hong J-Y, Ding X. Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone. Cancer Res. 2000;60(18):5074–9.PubMedGoogle Scholar
- 27.Devore NM, Meneely KM, Bart AG, Stephens ES, Battaile KP, Scott EE. Structural comparison of cytochromes P450 2A6, 2A13, and 2E1 with pilocarpine. FEBS J. 2011.Google Scholar
- 33.Marcia de Figueiredo R, Thoret S, Huet C, Dubois J. Palladium-catalyzed intramolecular arylation of N-Benzyl-2-iodoimidazoles: a facile and rapid access to 5H-imidazo[2,1-a]isoindoles. Synthesis. 2007;2007(4):529–40.Google Scholar